Grifols, S.A. (BME:GRF)
Spain flag Spain · Delayed Price · Currency is EUR
10.75
+0.02 (0.19%)
At close: Dec 5, 2025

Grifols Revenue

Grifols had revenue of 1.87B EUR in the quarter ending September 30, 2025, with 4.04% growth. This brings the company's revenue in the last twelve months to 7.52B, up 7.31% year-over-year. In the year 2024, Grifols had annual revenue of 7.21B with 9.41% growth.

Revenue (ttm)
7.52B
Revenue Growth
+7.31%
P/S Ratio
0.87
Revenue / Employee
315.89K
Employees
23,833
Market Cap
6.53B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20247.21B620.41M9.41%
Dec 31, 20236.59B528.01M8.71%
Jan 1, 20236.06B1.13B22.92%
Dec 31, 20214.93B-406.92M-7.62%
Dec 31, 20205.34B241.35M4.73%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Laboratorios Farmaceuticos Rovi 724.20M
Almirall 1.09B
Faes Farma 571.12M
Pharma Mar 179.28M
Clínica Baviera 296.76M
Oryzon Genomics 7.36M
Prim, S.A. 240.68M
Laboratorio Reig Jofre 330.34M
Revenue Rankings